Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. Cedars-Sinai Medical Center, Los Angeles, CA, United States

Survival: 20.9 months
Toxicity Grade: 5
Treatments: Chemotherapy
Country: United States
City/State/Province: Los Angeles, CA
Hospital: Cedars-Sinai Medical Center
Journal: Link
Date: 2/2012

This study involved women with recurrent ovarian cancer who were separated into two separate treatment groups. Group A had 53 patients with a median age of 59 years. Group B had 55 patients with a median age of 62 years.

Patients in group A were treated with the chemotherapy agent paclitaxel and the biologic therapy agent AMG386, which is an inhibitor of proteins involved in getting a blood supply to the tumor.

Patients in group B were treated with paclitaxel only.

There was one treatment-related death due to an unspecified cause in group A. Grade 3 or higher nerve effects, blood clotting, and bleeding were also reported.

There were 5 treatment-related deaths due to progressive disease and unspecified causes in group B. Blood clots, fatigue, and abdominal pain were also reported.

The median overall survival rates for groups A and B were 22.5 and 20.9 months, respectively.

This study was supported by the pharmaceutical company Amgen, makers of AMG 386.

Correspondence: Dr. Beth Y. Karlan; email:

E-mail to a Friend Email Physician More Information